Doxper is a technology company.
Doxper has raised $4.0M across 1 funding round.
Doxper has raised $4.0M in total across 1 funding round.
Doxper is an AI-powered healthcare technology company that provides a digital pen and encoded paper solution for instantly digitizing doctors' case sheets and prescriptions without altering clinical workflows.[1][2][3] It serves individual clinics, large hospitals, and public health settings in India, solving the problem of manual paperwork in outpatient departments (OPD) by enabling seamless data capture, structured analytics, and integration with electronic medical records (EMR) and India's Ayushman Bharat Digital Mission (ABDM).[2][3][6] Founded in 2015, Doxper raised $5.85M before being acquired by Meddo Health in August 2021, achieving high adoption rates (96% across clinics and hospitals) and digitizing millions of records from hundreds of doctors and hospitals in multiple cities.[1][2][6]
Doxper was founded in 2015 by InformDS Technologies in Bengaluru, India (with early presence in Maharashtra, Mumbai), as India's pioneering solution for OPD digitization amid healthcare's lag in adopting digital tools compared to other industries.[2][3][6] The idea emerged from recognizing doctors' resistance to screen-based entry, leveraging existing digital pen technology but tailoring it with healthcare-specific innovations like AI-driven medical handwriting recognition (initial ~95% accuracy after modeling 100-300 samples).[3][4] Early traction included deployments for clinical trials, remote public health (e.g., COVID-19 screening), and partnerships like Wockhardt Hospitals since 2021, establishing it as the largest source of longitudinal real-world outpatient data in India.[3][4][6]
Doxper rides the wave of AI-driven healthcare digitization in India, aligning with government initiatives like ABDM to create a unified digital health ecosystem and address the sector's paper-heavy OPD workflows.[2][3][6] Its timing capitalizes on post-COVID demands for real-time data in screening/testing and the global push for interoperable EMRs amid rising chronic disease surveillance needs.[4] Market forces favoring it include India's healthcare tech boom, pharma's hunger for real-world evidence, and scalability without infrastructure overhauls, influencing the ecosystem by providing the largest outpatient data repository to enable predictive analytics, policy-making, and targeted care.[3][5][6]
Post-acquisition by Meddo Health, Doxper is poised to expand its AI pen solution nationally and potentially globally, leveraging Meddo's network for deeper hospital integrations and pharma partnerships.[1] Trends like generative AI for clinical notes, real-time surveillance, and ABDM maturity will amplify its data assets for AI-driven insights in patient journeys and rare disease registries.[3][6] Its influence may evolve from digitization pioneer to foundational data platform, powering precision medicine in emerging markets—reinforcing its role as the seamless bridge from pen to predictive healthcare.
Doxper has raised $4.0M in total across 1 funding round.
Doxper's investors include Alkemi Growth Capital.
Doxper has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in August 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2019 | $4.0M Series A | Alkemi Growth Capital |